Clinical Trial

Maralixibat for Intrahepatic Cholestasis of Pregnancy

Name: Maralixibat for Intrahepatic Cholestasis of Pregnancy — clinical trial record (NCT07389031)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: METAPHOR

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

An open label phase 2a/b trial of maralixibat in patients with Intrahepatic Cholestasis of Pregnancy (ICP) and elevated serum bile acid concentrations (sBA) to evaluate safety and tolerability

Trial Details

NCT Number	NCT07389031
Lead Sponsor	Imperial College London Collaborators: Mirum Pharmaceuticals, Inc.
Conditions	Intrahepatic Cholestasis of Pregnancy
Enrollment	28 participants
Start Date	2026-04-01
Primary Completion	2028-03-31 (estimated)
Study Completion	2028-03-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-05